Streetbeat News

ICCT

iCoreConnect Inc.

Open

0.17

Mkt cap

1.9M

Volume

1.3M

High

0.17

P/E Ratio

-0.05

52-wk high

3.20

Low

0.16

Div yield

N/A

52-wk low

0.15

ICoreConnect shares rose following the announcement of its decision to divest its managed service provider division.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:04 pm

iCoreConnect has agreed to sell its Managed Service Provider division to The 20, LLC through an asset sale. The terms of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:02 pm

iCoreConnect Inc. (NASDAQ:ICCT) has expanded its partnership with the Mississippi Dental Association (MDA), which now endorses seven of iCoreConnect's products. This expansion includes products for revenue cycle management and patient experience, building on the initial endorsement of iCoreRx software.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:44 pm

iCoreConnect has entered into a channel partner agreement with DSO MarketWatch to improve business intelligence solutions for over 2,700 dental support organizations and 150,000 solo practicing dentists.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:32 pm

iCoreConnect shares are trading higher after the company reported a year-over-year increase in Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 8:39 pm

iCoreConnect reported its Q2 earnings with an EPS of $(1.10) and revenue of $3.087 million.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 8:33 pm

iCoreConnect has announced a reseller agreement with mConsent to integrate its iCoreRx ePrescribing software into mConsent's patient engagement platform. This partnership aims to enhance mConsent's digital solutions for dental practices by providing advanced prescription workflow and patient safety features.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 12:41 pm

iCoreConnect has expanded its partnership with the California Association of Orthodontists, which could enhance its market presence and customer base in the orthodontic sector.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 12:43 pm

Shares of Sharps Technology, Inc. (NASDAQ:STSS) surged 31.7% in pre-market trading after receiving two purchase orders for approximately one million SecureGard syringes for 2024 delivery. Other notable pre-market movers include Qualigen Therapeutics, Inc. (NASDAQ:QLGN) up 53%, Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) up 18.7%, and Adamas One Corp. (NASDAQ:JEWL) down 19.3%.

Portfolio Pulse from Avi Kapoor

July 05, 2024 | 3:01 pm

Fastenal Company's shares dropped by around 7% due to disappointing Q1 FY24 financial results, with sales and EPS missing consensus estimates. Other stocks experienced significant movements, with Rallybio Corporation, Rent the Runway, and Eliem Therapeutics among the top gainers, while Aptevo Therapeutics, Enlivex Therapeutics, and AVITA Medical led the losers.

Portfolio Pulse from Avi Kapoor

April 11, 2024 | 5:33 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.